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Gene duplication is a characteristic feature of eukaryotic
genomes. Here we investigated the role of gene duplication in
the evolution of the gloverin family of antibacterial genes
(Bmglv1, Bmglv2, Bmglv3, and Bmglv4) in Bombyx mori. We
observed the following two significant changes during the
first duplication event: (i) loss of intronV, located in the
3-untranslated region (UTR) of the ancestral gene Bmglv1,
and (ii) 12-bp deletion in exon3.We show that loss of intronV
during Bmglv1 to Bmglv2 duplication was associated with
embryonic expression of Bmglv2. Gel mobility shift, chroma-
tin immunoprecipitation, and immunodepletion assays iden-
tified chorion factor 2, a zinc finger protein, as the repressor
molecule that bound to a 10-bp regulatorymotif in intronV of
Bmglv1 and repressed its transcription. gloverin paralogs that
lacked intronV were independent of chorion factor 2 regula-
tion and expressed in embryo. These results suggest that
change in cis-regulation because of intron loss resulted in
embryonic expression of Bmglv2-4, a gain of function over
Bmglv1. Studies on the significance of intron loss have
focused on introns present within the coding sequences for
their potential effect on the open reading frame, whereas
introns present in the UTRs of the genes were not given due
attention. This study emphasizes the regulatory function of
the 3-UTR intron. In addition, we also studied the genomic
loss and show that “in-frame” deletion of 12 nucleotides led
to loss of amino acids IHDF resulting in the generation of a
prepro-processing site in BmGlv2. As a result, the N-terminal
pro-part of BmGlv2, but not of BmGlv1, gets processed in an
infection-dependent manner suggesting that prepro-proc-
essing is an evolved feature in Gloverins.
Insects depend on humoral (antimicrobial peptide (AMP)3
synthesis) and cellular responses to effectively kill the invading
microbes (bacteria and fungi) as they lack adaptive immunity
capable of producing antibodies (1). Typically AMPs have low
molecular weight, are water-soluble, and possess broad spec-
trum antibacterial activity (2). Cecropins, attacins, drosocins,
and diptericins have antibacterial activity against Gram-nega-
tive bacteria, whereas defensins and metchnikowin kill Gram-
positive bacteria (2, 3). Specificity in the immune response
against a particular class ofmicrobes is because of specific inter-
action between pathogen-associated molecular patterns pres-
ent on the microbes and pathogen recognition receptors of the
insect (1, 4). Because of the polyvalent recognition of pathogen-
associated molecular patterns, any microbial infection leads to
production of the same battery of AMPs through two evolu-
tionarily conserved pathways toll or imd (1, 4).
The Toll and IMD pathways mediate regulation of innate
immune response in insects, in response to fungal and bacterial
infections, respectively (1, 4). Dorsal was the first transcription
factor to be identified as regulator of innate immunity in Dro-
sophila. Ip (5) identified Dif (Dorsal related immunity factor), a
second Drosophila Rel protein, in the larval fat body. Drosoph-
ila Rel proteins are found in the cytoplasm but are translocated
to the nucleus upon activation of the immune pathway in a
signal-dependent manner. An extracellular signal, encoded by
the spatzle gene, binds to Toll, a membrane-bound receptor.
Spatzle binding to Toll causes activation of a signal cascade
involving Tube and Pelle, a serine/threonine kinase. This leads
to phosphorylation and subsequent degradation of Cactus, an
IkB homolog (1, 4). In the absence of Cactus, Dorsal andDIF are
free to translocate to the nucleus, where they act as transcrip-
tion factors and initiate expression of AMP genes. A third Rel
factor, Relish, was isolated in a molecular screen for genes
whose expression is altered after infection (6). Relish is a com-
pound protein containing both Rel (activating) and IkB (inhib-
itory) domains (7). Upon infection, the Relish inhibitory
domain is proteolytically cleaved by dredd, a Drosophila
caspase, to release the active Rel protein (8). Genetic epistasis
studies and molecular analysis of gene function show that imd,
Relish components of a signaling pathway are distinct from the
Toll pathway and are essential for combating Gram-negative
bacterial infection (8–15).
Although the mechanism of AMP activation has remained
conserved across species, the repertoire of AMPs present in
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different organisms varies (1–4) e.g. hemolin, an AMP with an
immunoglobulin fold (16), has been reported only from lepi-
dopteran insects. This prompted us to look for Lepidoptera-
specific AMPs in Bombyx mori with a broader aim to under-
stand the evolution of immune system in insects. B. mori is the
only lepidopteran insect for whichwhole genome sequence (17,
18) and EST data base (19) are available. An analysis of B. mori
genome and EST sequence revealed the presence of AMPs like
cecropins, moricins, attacins, lebocin, enbocin, hemolin, and
gloverins. Our analysis, based on sequence information avail-
able currently, suggests that like hemolin gloverins are also
restricted to lepidopteran insects.
Gloverins are glycine-rich (16–20%) antibacterial proteins
and have been reported from lepidopteran insects Hyalophora
gloveri, Helicoverpa armigera, and Trichoplusia ni (20–22).
They are basic, heat-stable proteins with random coil structure
in solution and take -helical structure upon interaction with
lipopolysaccharide (20).We found that silkworm has four glov-
erin genes (Bmglv1, Bmglv2, Bmglv3, and Bmglv4). The derived
genes Bmglv2–4 have evolved as a result of three gene duplica-
tion events. A significant difference was observed in the embry-
onic expression profile of these genes, whereas, derived genes
Bmglv2–4 express in all embryonic stages but not the ancestral
gene Bmglv1. This suggested that embryonic expression of
derived geneswas gained during duplication ofBmglv1. Embry-
onic regulation of AMP genes is not well studied; hence we set
out to study the genetic changes that led to evolution of embry-
onic expression in the Lepidoptera-specific AMP gene family,
gloverin. Molecular analysis suggested that embryonic expres-
sion ofBmglv1was regulated by an intron present in the 3UTR
of the gene. Further characterization of the regulatory role of
intronV led to identification of CF2, a zinc finger transcription
factor that regulates oogenesis as suppressor of Bmglv1 in the
embryo. We also tested the significance of embryonic expres-
sion of daughter gene Bmglv2, by RNAi which led to reduced
hatching of embryos. This indicated that Bmglv2 has a role in
embryonic development. We show that this gain of function in
embryonic development was linked to loss of intronV.
Introns, noncoding sequences interrupting protein-coding
genes, are the hallmark of eukaryotic gene organization (23).
However, the role of intron in AMP gene regulation was previ-
ously not known. This is the first study demonstrating the reg-
ulatory role of an intron in an AMP gene and association
between intron loss and gain of function. This study also
emphasizes evolution of functional divergence in AMP gene
paralogs.
EXPERIMENTAL PROCEDURES
Animals—B. mori strains Pure Mysore and Nistari were col-
lected from the sericulture station at Hindupur, Andhra
Pradesh, India. Escherichia coli (K12 strain), cultured in antibi-
otic free LB media, was used for infecting silkworm larvae.
Gel Shift Assay (EMSA)—Embryonic nuclear extracts were
prepared by homogenizing embryos (40–72 h AEL) in extrac-
tion buffer (20 mMHepes, pH 7.9, 5 mMMgCl2, 0.1 mM EGTA,
12.5% sucrose, 25% glycerol, 0.5 mMDTT, 0.5mM phenylmeth-
ylsulfonyl fluoride and protease inhibitor mixture) using a
Dounce homogenizer, followed by centrifugation at 3300  g
for 20 min at 4 °C. The precipitated nuclei were suspended in 1
ml of the extraction buffer. Embryonic extracts were also pre-
pared from w1118 and Df(2L)27 flies (these flies lack the cf2
locus). For EMSA, 100 ng of double-stranded cf2 oligonucleo-
tide (AGTAAATATATATATTTAAA) was labeled with 3 l
of [-32P]ATP (4 105cpm) and 1 l of polynucleotide kinase
(10 units/l) in 1 l of PNK buffer (New England Biolabs) for
1 h at 37 °C. The labeled DNA was purified on a G-50 column.
The binding reaction was performed for 30 min at room tem-
perature by mixing 1 ng of purified 32P-labeled double strand
synthetic oligonucleotide probe (4000 cpm/l), 10 g of
nuclear extracts, 300 ng of poly(dI-dC), and 5 mM Zn2 in the
presence of a protease inhibitor mixture (Sigma). Cold compe-
tition was performed by preincubating the extracts with a
40-fold excess of unlabeled oligonucleotide at room tempera-
ture for 15 min. Anti-CF2 monoclonal antibody was added to
the binding reaction for 30 min to perform supershift experi-
ments. The binding reaction was analyzed by electrophoresis
on native 6% polyacrylamide gels.
In Vitro Transcription and Translation—In vitro transcrip-
tion was done essentially as mentioned in Suzuki et al. (24, 25).
For in vitro translation, different expression constructs were
incubated with embryonic extracts prepared from Drosophila
or silkworm embryos. Embryos were collected, dechorionated
by bleaching, washed 3–5 times with 0.1% Triton X-100, and
transferred to hypotonic buffer at 4 °C. Embryos were further
washed in 3–5 volumes of cold hypotonic buffer (10mMHepes-
KOH, pH 7.4, 15 mM KCl, 1.5 mM Mg(OAc)2, 2 mM DTT) on
ice. Next, embryos were Dounce-homogenized, and homoge-
nate was centrifuged for 15 min at 15,000 rpm at 4 °C. The
supernatant was transferred to a fresh microcentrifuge tube
and centrifuged again under the same conditions to remove any
residual debris. Extracts were centrifuged through Sephadex
G-25 Superfine columns prepared in buffer A (30 mM Hepes-
KOH, pH 7.4, 100 mM KOAc, 2 mM Mg(OAc)2, 2 mM DTT,
protease inhibitor mixture). The column was transferred to a
fresh collection tube towhich a volume of cold bufferA equal to
the extract volume was added, and the column was centrifuged
for 3 min at 200 g at 4 °C. 100 l of eluate was applied to a P6
(Bio-Rad) desalting column to remove salt and other contami-
nants, and the desalted eluatewas used for in vitro translation as
mentioned in Gebauer et al. (26). Entire protocol was first stan-
dardized with CantonS Drosophila embryonic extracts (data
not shown), and then the standardized protocol was used for
experiments with B. mori embryonic extracts. B. mori embryos
were collected 40 and 56 h AEL and pooled.
Immunodepletion of Embryonic CF2—Immunodepletion
was done largely following the protocol as described previously
(27) with the following modifications. Immunodepletion of
CF2 was performed in embryonic extracts in a final volume of
500l of buffer A. CF2-depleted supernatant was collected and
used immediately for in vitro translation.
Western Blotting—In vitro translation reaction product was
separated on a 10% minigel SDS-polyacrylamide gel (Bio-Rad).
Protein samples separated by SDS-PAGE were electrophoreti-
cally transferred using a Trans-blot cell (Bio-Rad), at 200 mA
overnight at 4 °C to Hybond-P polyvinylidene difluoride trans-
fermembrane (AmershamBiosciences). The blots were stained
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for total protein by Ponceau S (Sigma) and blocked in 10% non-
fat dry milk in 0.5% Tween 20, 0.05% SDS in PBS (Blocking
buffer). The blots were incubated for 6 h at room temperature
in primary antibodies and thenwashed four times (10min each)
in Tween 20 PBS followed by a 2-h incubation at room tem-
perature with the secondary antibody (Sigma). The blots were
then washed three times for 30 min in Tween 20  PBS and
rinsed once in PBS. The protein bands were detected using
horseradish peroxidase-enhanced chemiluminescence (Amer-
sham Biosciences). Anti-CF2 (mouse) and anti-GST (rabbit)
antibodies were used in 1:10,000 and 1:1000 dilutions, respec-
tively, for probing.
RT-PCR, in Vitro Transcription, and RNAi—Total RNA was
isolated using TRIzol reagent (Invitrogen), dissolved in 50l of
RNase-free water, and quantified in a spectrophotometer. 1 g
of RNA was used in 20 l of RT reaction by using SupercriptII
(Invitrogen) and oligo(dT) or gene-specific primers. For syn-
thesizing dsRNA Bmglv1 and Bmglv2, PCR products were
cloned between BamHI and KpnI sites of pB-SK vector, and
in vitro transcription was done with linearized template using
T3 and T7 RNApolymerase, separately. Single strand RNAwas
purified after DNase treatment to remove template plasmid
and quantified in a spectrophotometer. An equal amount of
sense and antisense RNA was used for annealing in annealing
buffer by heating at 95 °C for 5 min followed by slow cooling to
room temperature. Respective dsRNA was injected on the 1st
day of 5th instar larvae. Male and female moths eclosed from
dsRNA injected larvae were allowed to mate (15 experiments
each for Bmglv1-dsRNA and Bmglv2-dsRNA), and egg hatching
was calculated. An equivalent volume of nontarget baculoviral
ie1-dsRNA was injected in control larvae. Different concentra-
tions of dsRNAwere used for standardization of RNAi, and the
data presented here are from larvae injected with 10 g of
dsRNA. A list of primers used for cloning of dsRNA target site
has been provided in the supplemental material.
Chromatin Immunoprecipitation—The protocol followed
forChIPwas essentially asmentioned on linewith the following
modifications. Instead of Staphylococcus aureus cells, proteinA
beads and silkworm embryo were used. Fluorescence real time
PCR was done with double-stranded DNA dye SYBR green
(PerkinElmer Life Sciences) on an ABI PRISM 7700 system
(PerkinElmer Life Sciences) to quantify the enrichment of the
cf2-binding element upon ChIP. PCR specificity was confirmed
by the molecular size of the PCR product and Ct analysis.
Reactions were done in triplicate and compared with input
DNAalso (in triplicate) and nontemplate control (in duplicate).
Plasmid Constructions—Full-length Bmglv1 cDNA was
cloned between BamHI andKpnI sites in pFB-His-GST expres-
sion vector to generate expression plasmid pFB-His-GST-Glv1.
This plasmid was later used for transforming DH10Bac bacte-
rial cells to obtain recombinant pFB-His-GST-Glv1 bacmid
that was subsequently transfected into Sf9 cells to get the
recombinant virus expressing His-GST-Glv1 fusion protein.
Maximum expression of the protein was observed between 70
and 96 h postinfection. His-GST-Gloverin1 fusion protein was
purified using a glutathione column. To generate expression
vectors with different promoters to be used in the in vitro trans-
lation reaction, Autographa californica nuclear polyhedrosis
virus (AcNPV) polyhedrinpromoter of pFB-His-GSTbasic vec-
tor was replaced with B. mori cytoplasmic actin (BmA3-Actin)
promoter (for control plasmid) or Bmglv1 or Bmglv2 promot-
ers. For cloning the intronV of Bmglv1, genomic PCR with
exon5- and exon6-specific primers (see supplemental material
for primer sequences), which amplified exon5-intronV-exon6,
was done, and subsequently this PCR product was cloned
downstream to gst only or gst  glv1 fusion ORF
(Bmglv1::GST-glv1-intronV plasmid). Control plasmid lacking
intronV was also generated by RT-PCR using same set of prim-
ers and cloned downstream to gst or other ORFs
(Bmglv1::GST-glv1-intronV plasmid). To study the role of
CF2-binding motif of intronV, a deletion construct lacking cf2
motif was generated by MseI digestion that deleted 53 nucleo-
tides just before intronV-exon6 junction. MseI-digested prod-
uct was blunt-ended, ligated, and then cloned downstream to
gst to generate Bmglv1::GST-glv1-IntronVcf2 plasmid. For
immunodepletion, a plasmid expressing GST-BmGlv1 fusion
protein (Bmglv1::Gst-Bmglv1(ORF)-InVcf2) was generated by
cloning Bmglv1ORF between gst and the Ex5-InV-Ex6 cassette
in the plasmid Bmglv1::gstEx5-InV-Ex6.
RNase Protection Assay—Exon5-intronV-Exon6 and Exon5-
intronVcf2-Exon6 fragments were PCR-amplified from the
respective plasmid (described in preceding paragraph) con-
structs using 3-UTR forward and reverse primers (see supple-
mental Methods) and cloned in pCR2.1 vector (Invitrogen).
The radiolabeled antisense strand was synthesized using T7
RNA polymerase (New England Biolabs) in an in vitro tran-
scription reaction. 5 g of RNA sample was hybridized with in
vitro transcribed antisense RNA probe (3  105 cpm) at 45 °C
overnight. RNA samples were dissolved in 25 l of 75% form-
amide, 0.5 M NaCl, 10 mM Tris-HCl, pH 7.5. RNase A (100
g/ml) was added to the reaction mix along with 200 l of 200
mMNaCl, 5mMEDTAand incubationwas done for 1 h at 37 °C.
After the RNase incubation, proteinaseK (250g/ml) digestion
was done followed by phenol/chloroform extraction and etha-
nol precipitation and finally subjected to denaturing (8 M urea)
PAGE.
Antibacterial and Prepro-processing Assay—Antibacterial
activity of BmGlv1 and BmGlv2 was determined by incubating
105–106 cells/ml of E. coli with 5 mM of either BmGlv1 or
BmGlv2 in 1 PBS, pH 7.1; and 1, 2, 4, and 6 h postincubation,
the optical density of the respective cultures was taken, and a
graph was plotted. Each experiment was repeated a minimum
of three times. Antibacterial activity of BmGlv1 and BmGlv2
was also quantified by counting the number of surviving bacte-
ria after 6 h of incubation in the presence of BmGlv1 or BmGlv2
(colony-forming units/ml) on antibiotic-free LB agar plates. In
a control experiment, bacteria were incubated with an equiva-
lent amount of PBS.
Bacterial challenge activates different proteases that in turn
cleave the N-terminal prepro part and release mature AMPs.
Hence, fat body extracts from E. coli-challenged 5th instar lar-
vae were prepared 3, 6, 9, and 12 hours post infection and
pooled. Later, purified GST-Glv1 and GST-Glv2 proteins were
incubated with the pooled fat body extract for 2 h, and then the
complete reactionmixture was separated on SDS-polyacrylam-
ide gel followed by Western blotting with anti-GST antibody.
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Release of GST-specific bandwas an indication of processing of
the AMP.
Phylogenetic Analysis of Bombyx Gloverins—Best fit model
was tested using Model Test as implemented in HyPhy.
GTRGmodel was selected by both Hierarchical Model Test-
ing andAkilike InformationCriteria (AKI score 13034.9) and
  2.00475. Using these parameters, a neighbor joining tree
was constructed.
RESULTS
Identification of Gloverin Family of AMP Genes in B. mori—
We have identified four gloverin genes (named as Bmglv1,
Bmglv2,Bmglv3, andBmglv4) in the silkwormB.mori.The gene
structures of silkworm gloverins revealed Bmglv1 (3.99 kb) as
the largest gloverin (Fig. 1A). Gene structure of Bmglv4 could
not be predicted reliably because of the presence of repetitive
elements in the scaffold corresponding to exon1. Exons 2–4,
which constitute ORFs, are highly conserved in all four glover-
ins. Phylogenetic analysis based on ORFs of the four gloverins
suggested Bmglv1 as the ancestral gene (Fig. 1B, supplemental
Fig. 1, and supplemental Table 1). Clearly, Bmglv1 is ortholo-
gous to other gloverins as it shares a common ancestor with
Manduca sexta and Trichopusia ni gloverins (Fig. 1B). The
presence of intronV is the one major difference between
Bmglv1 and the other three silkworm gloverins (Fig. 1B). How-
ever, intronV of Bmglv1 was lost during first duplication lead-
ing to fusion of exon5 and exon6 as a result of which the derived
gene Bmglv2 has only five exons. In subsequent duplication
events, lengths of different exons largely remained conserved
but not of introns (Fig. 1A). Although no clear pattern is seen in
intron length dynamics, overall the gene size has become
smaller with each round of duplication, precisely because of
FIGURE 1. Location, organization, andevolutionofBombyxgloverins.A, Bmglv1has six exonswhereas other paralogs have five. During the first duplication
event loss of intronV led to fusion of exons 5 and 6 resulting in smaller Bmglv2 gene. Intron loss does not change ORF. Start codon (green arrow) lies in the 2nd
exon,whereas stop codon (red star) lies in the 5th exon in all paralogs.B,phylogenetic analysis suggestsBmglv1 as the ancestralgloverinofB.mori. AttacinB and
AttacinDofDrosophilawereused as outgroup.Bm, B.mori;Dm,D.melanogaster;Ms,Manduca sexta; Tn, Trichoplusia ni. C, chromosomal locationof fourBombyx
gloverins as determined by physical mapping. Arrows (in black) indicate the sequence of duplication, and 1–3 3 indicate first, second, and third duplication
events, respectively.
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erosion in intronic regions of the genes (Bmglv1(3.9 kb) 3
Bmglv3 (2.9 kb)). Among the conserved introns (introns I–IV),
a significant deletion in intron length is seen for intronII, during
Bmglv2 to Bmglv3 duplication; however, significance of this
deletion remains to be elucidated (Fig. 1B).
Sizes of different gloverins may also differ because of size
variations in their UTRs. Fifth exon contributed to 3-UTR in
all the gloverins except Bmglv1, which has an additional 6th
exon as well as part of 3-UTR.
Bmglv3 has the longest 3-UTR (318
bp) and shows five unique inser-
tions not shared by other gloverins
(supplemental Fig. 1 and supple-
mental Table 1). Apart from this,
3-UTRs of four gloverins also share
low homology at the sequence level.
Lack of conservation in A/T-rich
3-UTRs of gloverins possibly indi-
cates lack of conserved regulatory
function.
We also confirmed the physical
location of the four gloverins.
Although Bmglv1, Bmglv3, and
Bmglv4 were physically mapped to
chromosome 28, Bmglv2 was
mapped to chromosome 17 (Fig.
1C).4 Bmglv1 and Bmglv4 are pres-
ent as tandemly duplicated genes
on positive strand at 38.6 3 45.0
centimorgans, and Bmglv2 and
Bmglv3 are present on the comple-
mentary strand at 0 centimorgans
416.4 centimorgans on chromo-
some 17 and at 22.83 37.3 centi-
morgans on chromosome 28,
respectively (Fig. 1C).
Bmglv1 Is Not Expressed in Embryo
UnlikeOtherAMPGenes—Induction
of expression of AMP genes in larval
and adult tissues, mainly fat body
and mid-gut, upon immune chal-
lenge is an established fact (1). How-
ever, we observed basal expression
of Bmglv2–4 in embryonic stages
(Fig. 2A). Other than Bmglv2-4,
attacin and hemolin genes are also
expressed in all embryonic stages.
Significantly Bmglv1 does not
express in embryos (Fig. 2A). A
more interesting developmental
regulation of AMP expression was
observed in gonads as we found that
Bmglv1 is expressed in larval but not
in adult gonads, whereas hemolin
and other gloverins expressed in
adult but not in larval gonads (Fig.
2B). Clearly, down-regulation of
Bmglv1 starts in adult gonads, and
complete repression is achieved in embryonic stages, and upon
hatching its expression is restored. It also suggested that
embryonic expression may be a general feature of AMPs. The
study raised two questions as follows. (i) What is the signifi-
cance of embryonic expression of AMPs in general? (ii) How is
suppression of Bmglv1 achieved in embryonic stages?
4 K. Mita, personal communication.
FIGURE 2. Expression dynamics of gloverin and other AMP genes of B. mori. A, all AMPs express in embry-
onic stages except for Bmglv1. (Numbers at the top indicate hours AEL; hat indicates hatched larvae.) B, Bmglv1
(arrowhead), which expresses in larval gonads, is down-regulated in adult gonads. Contrary to Bmglv1 down-
regulation, hemolin is up-regulated in adult gonads, and its expression was not seen in larval gonads. Attacin
expression did not change appreciably. (m, HindIII marker; T, testes; O, ovary.) C, knockdown of Bmglv2 by
RNAi leads to30% reduction in embryohatching (p 0.001), whereas knockdownof Bmglv1has no effect on
hatching. Data shownhere are the average of five independent experiments.D, RT-PCRwas donewith embry-
onic RNA (40 h AEL) to show inhibition of Bmglv2 upon RNAi (lane 3). Lane 4 shows enhanced expression of
Bmglv2 (with respect to lane 2) where larvae were injected with ie-1 dsRNA followed by E. coli infection thus
confirming that ie-1 dsRNA injection does not target Bmglv2 transcript. (Lane 1, without RT control; lane 2,
nontarget ie-1dsRNA control; lane 3, Bmglv2dsRNA; lane 4, ie-1 dsRNA Bacterial injection.). Beta actin, loading
control. Numbers above the figure represent respective lanes.
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Significance of Embryonic Expression of Bmglv2—Embryos
are naturally protected against microbial infection because
of the presence of the impregnable chorion layer that pro-
vides a strong physical barrier. Hence, embryos are not
prone to infection nor has any natural infection been
reported in insect embryos. If the threat of microbial infec-
tion is low/absent in embryos, then to what purpose does
expression of AMPs in embryonic stages serve? We hypoth-
esized that AMPs may have some role other than killing
microbes. To test this hypothesis, we knocked down the
embryonically expressing gloverin paralog Bmglv2 and com-
pared the effect of its knockdown with that of Bmglv1 knock-
down. Bmglv1 and Bmglv2 dsRNA were administered to 4th
and 5th instar larvae and later injected into adult moths as
well. Knockdown effect was ana-
lyzed in the next generation
embryo. Although RNAi of
Bmglv2 led to reduced hatching,
knockdown of Bmglv1, which does
not express in embryo, had no such
effect (Fig. 2,C andD). These results
suggest a role for Bmglv2 in embry-
onic development that indicates a
gain of function in Bmglv2 with
respect to Bmglv1. Thus our results
point out that embryonic expres-
sion of AMPs (Fig. 2A) is an essen-
tial and developmentally regulated
process.
Bmglv1 Promoter Is Functional in
Embryo—Developmental regula-
tion of AMP genes is not well stud-
ied. Because Bmglv2 and Bmglv1
genes were quite distinct in their
embryonic expression pattern, we
examined the differences between
the two genes to gain insight into
their embryonic regulation (Fig.
2A). Promoters are the most impor-
tant cis-elements that regulate spa-
tio-temporal expression of down-
stream genes. One possibility was
that during the duplication process,
certain regulatory motifs in the pro-
moter of Bmglv2 might have been
deleted/gained leading to its expres-
sion in embryo and was further
investigated. Comparative analysis
of gloverin promoters revealed
binding sites of all essential tran-
scription factors, which regulate
AMP genes, viz. Rel and GATA
(data not shown), and we did not
find any striking difference between
the two promoters. Hence, we
tested whether the Bmglv1 pro-
moter was functional in embryonic
stages or not. Bmglv1::gst plasmid,
where gst is driven by theBmglv1 promoter, was incubatedwith
embryonic extract for coupled in vitro transcription and trans-
lation experiments. Synthesis of GST from Bmglv1::gst plasmid
was indicative of the fact that theBmglv1 promoter was capable
of expressing in embryonic stages similar to that ofBmglv2 (Fig.
3A, lanes 2 and 3). BmA3-Actin promoter (cytoplasmic actin
promoter of B. mori) construct was used as reaction control
(Fig. 3A, lane 4). Because both the promoters were functional
during embryonic stages, we looked for other differences
between the two genes that can account for different embryonic
expression profile of the two genes. It is evident that the gene
structure of gloverin paralogs has largely remained unchanged
with the exception of intronV, which is present only in Bmglv1
(Fig. 1B). As loss of intronV and gain of embryonic expression
FIGURE 3. Characterization of repressor element in the 5th intron of Bmglv1. A, in vitro synthesis of GST
from plasmid driven by Bmglv1 (lane 2) and Bmglv2 promoters (lane 3) suggests that the Bmglv1 promoter is
functional in theembryo. Constitutively activeA3-actinpromoter (lane 4)wasusedaspositive control,whereas
AcNPV polyhedrin (Polh) promoter (lane 1), which requires viral factors for expression, was used as negative
control. B, schematic diagram shows organization of expression plasmids used to study the interaction
between promoter and intronV. Upper panel shows plasmid with intronV, and the lower panel shows plasmid
without intronV. In both constructs Ex5-InV-Ex6 or Ex5-Ex6 cassette was cloned downstream to the gstORF. C,
in vitro translation product is synthesized with Bmglv1::gst-Ex5-Ex6 template lacking intronV but not with
Bmglv1::gst-ex5-inV-ex6 template thus suggesting inhibitory role of intronV. -Tubulin was used as control
(lower panel). D, nuclear extracts from different developmental stages of silkworm were used for retardation
with CF2-specific probe to check tissue-specific expression of CF2 protein. Expression profile of CF2 and that of
Bmglv1 are inversely correlated (compare with Fig. 2, A and B). Lane 1, cold competition; lane 2, nonhomolo-
gousmutant competition; lane 3, adult testes; lane 4, adult ovary; lane 5, homologousmutant CF2 probe; lane
6,midgut; lane 7, fat body; lane 8, larval ovary; lane 9, larval testes; lane 10, freeprobe; lane 11, embryo40-hAEL;
lane 12, embryo 60-h AEL; lane 13, embryo 96-h AEL; lane 14, drosophila ovary; lane 15, Drosophila embryo. E,
supershift with Drosophila CF2 antibody was done to check the specificity of the complex retarded with CF2
oligonucleotide. Lane 1, Drosophila embryo; lane 2, silkworm embryo 40-h AEL; lane 3, nonhomologous com-
petition; lane 4,CF2-antibody silkwormembryo40-hAEL; lane 5,CF2-antibodyDrosophilaembryoextract;
lane 6,CF2-antibody cold competition; lane 7,CF2-antibodynonhomologous competition; lane 8, embry-
onic extract fromDf(2L)27 stock that lacks CF2 locus; lane 9, free probe. F, ChIPwith CF2monoclonal antibody
suggests in vivo interaction of CF2with Bmglv1-intronV. Larval fat bodywhere CF2 is not expressedwas used as
negative control. G, real time PCR was done to quantify the enrichment of Bmglv1-intronV in ChIP performed
with embryonic extract and shows only 32% enrichment with respect to input. Weak enrichment of intronV
upon ChIP with respect to control is probably because Drosophila anti-CF2 monoclonal antibody has been
used to precipitate silkworm CF2 protein with which the antibody may not interact with the same efficiency.
Error bars represent standard deviation of three independent experiments.
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took place during the 1st duplication, we investigated whether
the two events were linked.
IntronV of Bmglv1 Acts Like a Repressor—Introns are non-
coding parts of the gene, but they are essential segments of the
genome as many of the introns are known to have regulatory
functions such as enhancers and suppressors. To ascertain the
embryo-specific regulatory role, if any, of intronV of Bmglv1,
we constructed gst reporter plasmids under the control of the
native Bmglv1 promoter. IntronV is located downstream to the
ORF in the 3-UTR region of the Bmglv1 gene; hence, to retain
this natural organization, intronV along with flanking regions
of exons 5 and 6 was cloned downstream to the reporter gst
ORF (Fig. 3B). In the control plasmid intronV was not cloned.
Both plasmids, driven by Bmglv1 promoters, were incubated
with Bombyx embryonic extracts for coupled in vitro transcrip-
tion and translation of the reporter gene. GST synthesis took
place in the reaction where control plasmid was used, and no
GST was detected in the reaction performed with the plasmid
that harbored intronV (Fig. 3C), thus suggesting that intronV
had inhibitory action on GST synthesis. Next we set out to
dissect the mechanism of embryonic suppression of Bmglv1
gene by intronV.
Identification of Repressor Element in IntronV of Bmglv1—In-
tronV of Bmglv1 is 279 bp long, and to characterize the motif
regulating embryonic expression of upstream ORF, EMSA was
done with different fragments of intronV generated by restric-
tion digestion (data not shown). The fragment corresponding
to the last 40 bp of the intron, which has a putative CF2 binding
site, showed specific shift in EMSA. Although there are two
additional CF2-binding motifs in the intron, only the one pres-
ent near the intron5-exon6 boundary was found to be func-
tional (supplemental Fig. 2). Later oligonucleotide (2AGTA-
AAATATATATAT) corresponding to the “functional
CF2-bindingmotif” was used as probe for gel shift. TheCF2 com-
plex could be retarded with nuclear extracts from adult ovary,
testes, and embryonic extracts but not from tissues of larval
origin (Fig. 3D). These results are consistent with the observa-
tion thatBmglv1 expression is not seen in the tissueswhereCF2
is expressed (Fig. 2A and Fig. 3D). Supershift with Drosophila
CF2 antibody confirmed that the retarded complex contained
CF2 protein (Fig. 3E). No gel shift was seen when embryonic
extract fromDf(2L)27 flies, which lack cf2 locus, was used (Fig.
3E, lane 8). This further confirmed the specific interaction of
CF2 to the intronic element. To test the interaction of CF2 to
intronV under in vivo conditions, ChIP assay was performed
(Fig. 3, F and G). The enrichment of intronV was seen with
embryonic but not with fat-body extract (Fig. 3F). These results
point out the presence of a CF2-mediated active regulatory ele-
ment in the intronV of Bmglv1 and also the apparent correla-
tion between Bmglv1 repression and expression of CF2.
Binding of CF2 to IntronV of Bmglv1 Represses the Native
Promoter—The physical interaction between CF2 and intronV
suggested that CF2 might be important for intron-mediated
suppression of the Bmglv1 gene. To establish that CF2 was
required for intronV-mediated repression of Bmglv1, we per-
formed in vitro translation of Bmglv1::Gst-Bmglv1(ORF)-InV
and Bmglv1::Gst-Bmglv1(ORF)-InV plasmids, with whole-
some and CF2-depleted embryonic extracts (CF2 protein was
immunodepleted using CF2 antibody). Western blot of in vitro
translation product of Bmglv1::Gst-Bmglv1(ORF)-InV plasmid
did not detect GST-BmGlv1 fusion protein in the reaction
where complete embryonic extract was used (Fig. 4A, lane 2),
but the fusion protein was detected in the reaction where CF2-
depleted embryonic extract was used (Fig. 4A, lane 1). Consti-
tutively expressing piggyBac-based BmA3Actin::GFP plasmid
(28) was used as reaction control (Fig. 4A). Synthesis of GST-
BmGlv1 fusion protein in the CF2-depleted extract suggested
that native Bmglv1 promoter was active in the embryo and also
that the presence of CF2 led to Bmglv1 suppression (Fig. 4A).
Furthermore, to prove that CF2-mediated repression of
Bmglv1 required binding ofCF2 to the intronV,we repeated the
immunodepletion experiment as mentioned in Fig. 4A, using
Bmglv1::Gst-Bmglv1(ORF)-InV plasmid that lacks the func-
tional CF2-binding motif in the intronV (intronV-cf2). It is
evident that in vitro translationwas not affected by the presence
or absence of CF2 in the embryonic extract if the CF2-binding
motif was deleted (Fig. 4B, lanes 1 and 2). Taken together, data
shown in Fig. 4, A and B, suggest that silencing of the Bmglv1
promoter required physical interaction between CF2 and
intronV of Bmglv1. This result was further confirmed when the
CF2 protein was differentially depleted by using different
FIGURE 4. CF2 represses Bmglv1 expression. A, immunodepletion of CF2
leads to synthesis of GST-Glv1 fusion protein in the presence of complete
intronV (lane 1). In the mock-treated reaction, fusion protein is not synthe-
sizedwhen CF2-bindingmotif is intact (lane 2). B, deletion of the cf2 binding
motif makes Bmglv1::gst-glv1InV-cf2 plasmid independent of CF2 regu-
lation thus suggesting that repressor function of CF2 is mediated by its
binding to the intronV. BmA3-actin::GFP control plasmid was also added in
the same reaction as reaction control in all experiments (A and B). Clearly,
green fluorescent protein synthesis is not affected by the presence or
absence of CF2. C, immunodepletion of CF2 has inverse effect on expres-
sion of Bmglv1 promoter and proves that CF2 inhibits Bmglv1 promoter in
a concentration-dependent manner. Lane 1, mock treatment where CF2
antibody was not added; lane 2, CF2 and PBS in 40:60 ratio; lane 3, CF2 and
PBS in 60:40 ratio. D, RNase protection assay suggests that binding of CF2
to Bmglv1-intronV-cf2 plasmid represses transcription in the presence of
CF2 (lane 3) but not when CF2 is depleted out (lane 2) or in mock control
(C, lane 1). Bmglv1::gst-glv1InV-cf2 plasmid was added as reaction con-
trol, and its transcription is not affected by CF2 presence/absence (lower
band). Upper panel shows the diagrammatic representation of the
expected sizes of transcripts protected from RNase digestion (RNase pro-
tection). M represents the two MseI sites that are 53 bases apart and
encompass the functional CF2-binding motif. Restriction digestion with
MseI deletes these 53 bases and thus generating a 288-bp-long glv1InV-
cf2 transcript, whereas the glv1InV-cf2 transcript is 343 bp long. Numbers
below the figures indicate respective lanes.
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amounts of CF2 antibody. Synthesis of GST-BmGlv1 protein
was found to be dependent on the extent ofCF2depletion in the
embryonic extract (Fig. 4C). These results establish that CF2
recruitment to intronV is essential for Bmglv1 suppression and
also suggest that CF2- mediated intronic regulation is domi-
nant over native Bmglv1 promoter.
Cf2 Blocks Transcription of Bmglv1—We have shown that
CF2 binding to intronV was required for suppression of GST-
BmGlv1 fusion protein synthesis (Fig. 4, A–C). Lack of protein
synthesis could be due to either suppression of transcription or
of translation. If intronV acted like a cis-regulatory element,
then transcription will be blocked (cis-regulation), and if the
regulation was at the RNA level, then transcript will be formed
but not the translation product. First, we tested whether CF2
binding to intronV suppressed transcription of Bmglv1. To
elucidate the mechanism of suppression by CF2, if intronV
acted like a cis-regulatory element, we performed in vitro
transcription experiment with Bmglv1::Gst-InVcf2 and
Bmglv1::Gst-InVcf2 plasmids. In vitro transcription was
done with CF2-depleted and control extracts. RNA synthesis
was checked by RNase protection assay (Fig. 4D). Because of
deletion of the cf2 motif, transcript formed from
Bmglv1::Gst-Bmglv1(ORF)-InVcf2 template is shorter by 53
nucleotides compared with transcript synthesized from
Bmglv1::Gst-Bmglv1(ORF)-InV template (Fig. 4D,upper panel).
When Bmglv1::Gst-InVcf2 plasmid was used as template in the
reaction where complete embryonic extract was used, no RNA
could be protected indicating absence of transcript in this reac-
tion (Fig. 4D, lower panel, lane 3). Protection of gst-Bmglv1-
inV-specific transcript in lane 2 indicates transcription of
Bmglv1::Gst-Bmglv1(ORF)-InV template with CF2-depleted
extract (Fig. 4D, lower panel). Synthesis of RNA was not
affected by the presence or absence of CF2 protein when the
Bmglv1::Gst-inVCF2 template, which lacks CF2-binding
motif, was used (Fig. 4D, lower panel, lower band). CF2 bound
to the intronV represses transcription from the Bmglv1 pro-
moter, thus confirming that intronV acts like a cis-regulatory
repressor element and not like a translational repressor.
This also explains that because of transcriptional repressor
action of intronV, mediated by CF2, Bmglv1 transcript is not
expressed in tissues where CF2 is expressed. On the other hand
Bmglv2–4 genes are independent of CF2 regulation as they lack
intronV. As loss of intronV was responsible for paradigm shift
in embryonic regulation of gloverin paralogs, we therefore
believe that this intron loss was a critical event in the evolution
of the gloverin family of genes in B. mori.
The Genomic Deletion—First duplication was also character-
ized by a genomic deletion in an exon of Bmglv1. Deletions in
exons have a direct effect on the nature and function of the
duplicated gene as most often it leads to a frameshift in ORF
that results in change in protein sequence or truncation of the
original protein.
Comparative analysis of silkworm gloverins revealed an in-
frame deletion of 12 bp in the exon3 of Bmglv1 (Fig. 5A). These
nucleotides code for amino acids Ile, His, Asp, and Phe. ClustalW
alignment of all known gloverins suggests that the presence of
IHDF is a unique feature of BmGlv1 as this sequence motif is
not present in other reported gloverin orthologs or paralogs
(Fig. 5B). RHPRDVTWD sequencemotif, which has the signal-
processing motif, is conserved in all gloverins except for
BmGlv1, which has an insertion of amino acids IHDF between
Asp and Val. This insertion might have potentially split/abro-
gated the processing site (Fig. 5B). Hence, we set out to study
the functional consequences of the presence/absence of IHDF
residues close to the prepro-processing site in BmGlv1.
BmGlv1 Is Not Processed upon Immune Challenge—AMPs in
general are synthesized with an N-terminal prepro region,
which keeps them in an inactive state (1–3). These prepro
regions usually contain a signal sequence, which probably helps
in their secretion. All the reported gloverins are known to have
a precursor region that has a cleavage site between arginine and
aspartate in the sequence RHPRDVTWD (Fig. 5B). However,
the presence of amino acids IHDF between aspartate and valine
of the cleavage recognition sequence has changed the sequence
motif next to the cleavage site in BmGlv1. To elucidate the
functional consequences of the presence of IHDF, recombinant
AcNPV expressing Bmglv1 and Bmglv2 genes containing His6-
GST tag at the N terminus was expressed in Sf9 cells. Purified
GST-BmGlv1 and GST-BmGlv2 proteins were incubated with
fat body extracts prepared from bacteria challenged and
unchallenged larvae.
The fat body extracts prepared from bacteria-challenged lar-
vae are rich in proteases that were either absent or inactive in
the extracts prepared from unchallenged larvae. These pro-
teases process AMPs by cleaving the N-terminal prepro part.
We designed an assay to test the processing of GST-BmGlv1
andGST-BmGlv2 proteins. GST-specific band, being upstream
to AMP, will only be released if the prepro part of the fused
AMP is processed. No GST-specific band was released from
either of the proteins when incubated with fat body extracts
prepared from unchallenged larvae (Fig. 5C, lanes 1 and 4).
However, the GST band was released from BmGlv2 but not
BmGlv1 upon incubation with fat body extracts prepared from
challenged larvae. Thus, release of the GST band in lane 3 indi-
cates N-terminal processing of BmGlv2 and not of BmGlv1
(Fig. 5C). These results demonstrate that insertion of IHDF has
abrogated the processing site in BmGlv1. However, lack of
N-terminal processing had no effect on antibacterial activity of
BmGlv1 as confirmed by zone inhibition and bacterial clear-
ance assay. In fact, BmGlv1 has stronger antibacterial activity
than BmGlv2 (0.05 M) and cleared bacteria faster than
BmGlv2 (0.1 M) (Fig. 5, D and E) implying that lack of proc-
essing is not critical for antibacterial activity of BmGlv1.
DISCUSSION
In the study reported here, we have explored the effect of
genome dynamics on the evolution of the gloverin family of
AMP genes. Our analysis suggests that Bmglv1 is the ancestral
gloverin, and other silkworm gloverins evolved in due course of
time as a result of three gene duplication events. One notable
feature of the first gene duplication was two gain of function
phenotypes associated with two deletion events. The first was
in-frame genomic deletion of 12 bp that led to gain of prepro
cleavage site, and the second was loss of an intron that changed
the expression pattern of the duplicated gene Bmglv2.
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Evolution of Prepro Domain in Gloverin Proteins—It is
known that precursor AMPs are produced with an N-terminal
prepro part containing signal sequence, which is important for
their activation (2, 3). Processing of the N-terminal prepro part
was considered as a property inherent to all AMPs. Because the
processing site sequence has remained conserved even in
orthologous gloverins (Fig. 1B), we reason that deletion of four
amino acids was not a random event but the result of an evolu-
tionary pressure to acquire the processing ability. In view of
these results it is tempting to propose that processing of AMPs
FIGURE 5. Prepro-processing of BmGlv1. A, exon3 of ancestral Bmglv1 has unique 12 nucleotides coding for amino acids IHDF (shown in red), but the same is
deleted in exon3ofBmglv2.B,multiple alignment of gloverins, as knownnow, reveals that IHDFmotif, next toprepro cleavage site (downward arrow), is unique
to BmGlv1. Otherwise BmGlv1 andBmGlv2proteins are 92% similar.C, to check prepro-processingGST-BmGlv1 andGST-BmGlv2bothwere incubatedwith fat
body extract prepared from unchallenged (U) (lanes 1 and 4) and E. coli challenged (C) 5th instar larvae (lanes 2 and 3). Release of GST band in lane 2 indicates
processing of GST-BmGlv2 into GST and BmGlv2 upon immune challenge, whereas absence of GST band in lane 2 indicates lack of processing of BmGlv1. No
processing of either of the proteins is seenwith extract prepared fromunchallenged fat body.D, lack of prepro-processingdoes not affect antibacterial activity
of BmGlv1 as seen in bacterial clearance assay. Shown here is the result of one representative experiment of the three such experiments done under identical
conditions. E, bar diagram shows number of bacteria surviving (number of colony-forming units 106/ml) after 6 h of treatment with equivalent concentra-
tionsof BmGlv1, BmGlv2, or PBS (control). Post-treatment thebacterial culturewaspelleteddown,washedoncewithPBS, and thendissolved in 200l of sterile
plain LB broth. 100l of the soupwas plated on antibiotic-free LB-Agar plates and incubated overnight after which the number of colonieswere counted. Five
replicates of each experiment were done, and p value was calculated.
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is an evolved character in gloverins of B. mori. It will be inter-
esting to investigate whether N-terminal processing in other
AMPs has also evolved in a similar manner. We believe that it
may be true for other AMPs as well and would most probably
require study of humoral immunity in primitive insects. How-
ever, based on our data, we hypothesize that Bmglv1may be the
relic of an ancestral and more primitive immune system.
Regulation of Bmglv1 Gene by 3-UTR Intron—Another sig-
nificant finding of this study is the functional characterization
of a regulatory element in intron of an AMP gene. The 5- and
3-untranslated regions (UTRs) that bracket CDSs are funda-
mental structural and regulatory regions of eukaryotic genes
(29–32). UTRs are known to contain large numbers of introns
(33), yet there is a lack of hypotheses specifically addressing the
evolution of introns within UTRs. A study by Pesole et al. (33)
suggests that intron density is higher in 5-UTRs than 3-UTRs.
The observation that fewer 3-UTRs carry introns is surprising
as 3-UTRs are generally longer than 5-UTRs and would thus
be expected to have higher intron density. The reason for the
lack of introns in 3-UTRs could be intron loss, which is most
often restricted to 3 introns (34, 35). Themost commonmech-
anism of intron loss is the gene conversion of original gene by
reverse transcription of spliced RNA (36–41).
Introns have been shown to affect the expression of different
genes at different levels like mRNA export, stability, and trans-
lation efficiency (42–44). But the role of introns in the regula-
tion of AMP genes is not reported. Here we have reported a
CF2-dependent intronic regulation of an AMP gene. In Dro-
sophila the CF2 protein exists in two isoforms CF2I and CF2II.
The 113-amino acid-long zinc finger domain of CF2 consists of
five to seven contiguous zinc fingers of the C2H2 type (45–48).
The zinc finger motif of CF2 resembles zinc finger domains of
the developmentally regulatedDrosophila transcription factors
Kruppel and hunchback. CF2 is basically a transcriptional acti-
vator and possesses transcription activation domain consisting
of 17 glutamines interspersed with 7 acidic residues (49). How-
ever, this study demonstrates that CF2 can act as a repressor as
well. This also suggests that action ofCF2 as activator or repres-
sor is context-dependent. This is the first study where CF2 has
beenshowntobind toan intronelementandrepress the transcrip-
tion of the native gene. CF2 bound to intronVmay lead to looping
back of the DNA, which in turn can silence the promoter (Fig. 6).
Involvement of factors other than CF2 in intronV-mediated, pro-
moter silencing cannot be ruled out.
Intron Loss in 3-UTR of the Gene Is Positively Selected—Fifth
intron of Bmglv1 splits the 3-UTR, implying that loss of intronV
would not have affected the BmGlv1 protein; hence this
intron loss could have been inconsequential from the evolu-
tion point of view. We show that loss of intronV did not alter
the gene product, but it changed developmental regulation of
Bmglv2 resulting in acquisition of a new function in embryonic
development. However, this gain of function, in the derived
gene Bmglv2, in embryonic development was because of its
ability to express in the embryonic stages. We have shown that
the embryonic regulation of promoters of both the ancestral
and the derived gene is the same; still the ancestralBmglv1 does
not express in the embryo because of repression by intronV in
embryonic stages (Fig. 3, A and B, and Fig. 4C). As intronV
regulation is dominant over the Bmglv1 promoter, the only way
to achieve embryonic expression was by losing intronV. Thus,
Bmglv1 would have experienced strong pressure to lose
intronV, which was eventually lost during the first duplication
process. In otherwords loss of intronV ofBmglv1was positively
selected to achieve embryonic expression, and it was not lost
randomly for being a 3-UTR intron. Thus, our study suggests
that loss of 3-UTR introns may be associated with distinct
phenotypes, and hence these introns could have experienced
positive selection.
AMPs Have a Role in Embryonic Development—The signifi-
cance of embryonic expression of AMPs is not clear. There are
very few reports on the role of AMPs in embryonic develop-
ment. Recently, hemolin expression has been shown to be
important for embryonic diapause and development (50, 51).
Embryonic diapause is a special physiological state that is devel-
opmentally controlled and is observed in many insects. A dia-
pausing embryo, where most of the physiological processes are
suppressed, is considered to be under stress, and it is suggested
that expression of hemolin in such embryos could be part of a
broad stress response (50, 51). We speculate that other AMPs,
FIGURE 6.Model to explain evolution of gloverin gene family by subneo-
functionalization. Our results suggest the presence of two regulatory ele-
ments as follows: (i) promoter (R1) and (ii) intronV (R2) in ancestral gloverin
(Bmglv1). We have shown that promoter regulation is same for both the
ancestral (Bmglv1) and the duplicated copy (Bmglv2); still expression of
Bmglv1 was not observed in embryonic stages because of inhibition of
Bmglv1 transcription in these tissues by CF2. However, this CF2-mediated
repression was mediated by intronV, which is present only in Bmglv1, the
ancestral copy. Thuswe identify intronV as the second regulator (R2) and also
show that R2 is dominant over R1 in embryonic stages. During the first dupli-
cation, intronV (R2), was lost resulting in embryonic expression of daughter
gene Bmglv2. Interestingly, embryonically expressing paralog Bmglv2 also
controls embryonic development, a feature not observed in Bmglv1, suggest-
ing gain of function for Bmglv2 (neofunctionalization). Loss of R2 is an exam-
ple of regulatory subfunctionalization which led to neofunctionalization of
Bmglv2, so the changes during first duplication event can be summed up as
subneofunctionalization.
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like gloverin paralogs, which express in the embryonic stages,
might be part of the same broad stress response. However,
embryonic expression of AMPs has also been reported from
Drosophila, which does not undergo diapause and hence dia-
pausemay not be the only function to be affected byAMPs (52).
Embryonic expression of cecropinA in Drosophila embryo was
detected in tissues like yolk and embryonic epidermis but not in
embryonic fat body, mid gut, or hemocytes. This is in stark
contrast to CecropinA expression in larval and adult stages
where it is expressed in fat body and mid gut (1). Furthermore,
GATA factor Serpent is needed for expression of AMPs in
embryonic yolk but not in embryonic epidermis (52) suggesting
that expression of AMPs in different tissues of the embryo is
regulated by different transcription factors.
Here we have shown negative regulation of ancestral gloverin
by embryonic protein CF2, which is expressed in yolk and con-
trols oogenesis (53). This study adds onemore dimension to the
embryonic regulation of AMPs, and more precisely it reveals
the evolution of embryonic regulation in an AMP gene family.
During the course of evolution, there have been episodes of
extensive intron loss and gain because of selective forces that
affect the rate of intron dynamics (54, 55). For evolutionarily
conserved genes, intron insertion supposedly had adaptive
effect like increasing stability of RNA, whereas intron loss was
found to be deleterious (43, 44, 56). This apparent functional
importance of introns could be due in part because of their
effects on gene regulation. Our study demonstrates the role of
intron as cis-regulators in gene evolution and thus adds another
dimension to genome plasticity. The fact that intron loss
achieved embryonic expression for gloverin paralogs, a prop-
erty which appears to be common feature of all AMP genes
except for Bmglv1, suggests that this intron loss might have
experienced positive selection. In an earlier study positive
selection of intron loss in Drosophila has been shown (57). To
the best of our knowledge this is the first report where positive
selection for intron loss in an AMP gene has been functionally
validated. In summary, our study suggests that intron loss or
gain may not be a passive/random feature of genome dynamics
but a result of selection pressure.
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